Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004

Translated title of the contribution: Achieving the target lipid levels in Hungary, 2004

László Márk, Károly Zámolyi, Gyula Pados, G. Paragh, Péter Ofner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Introduction: Recent European and Hungarian guidelines of cardiovascular prevention have clearly defined the target levels in lipid lowering therapy. Objective: To analyze the risk status of patients receiving long term lipid lowering therapy and the rate of achievement of target level in a Hungarian multicenter trial. Method: The investigation was performed in January and February of 2004 involving general practitioners and specialists (cardiologists, lipidologists). Applying a questionnaire the authors asked for risk factors and the further implementations in the knowledge of results of each doctors' 10 consecutive patients receiving lipid lowering therapy for at least one year. Results: LDL target levels accepted by the Hungarian Therapic Consensus Conference was achieved in 22% of GP's patients and 27% of specialists' ones, averagely in 24% of patients. According to risk stratification, the 83% of patients receiving lipid lowering therapy were at high risk, and 79% of these did not reach the suggested target level of serum total cholesterol. In 54% of patients not achieving target level the doctors continue the therapy without any modification. Considering therapy modification in the rest of patients, a dose increase was intended in 61%, change of drug in 31% of cases, and rarely the combination therapy. Conclusion: While only a quarter of patients receiving lipid lowering treatment achieved the target levels, along with wide spreading of this kind of therapy further efforts should be made in order to achieve the levels defined in guidelines with dose increase or combination of appropriate drugs.

Original languageHungarian
Pages (from-to)147-152
Number of pages6
JournalOrvosi Hetilap
Volume146
Issue number4
Publication statusPublished - 2005

Fingerprint

Hungary
Lipids
Therapeutics
Guidelines
Drug Combinations
General Practitioners
Multicenter Studies
Consensus
Cholesterol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Márk, L., Zámolyi, K., Pados, G., Paragh, G., & Ofner, P. (2005). Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004. Orvosi Hetilap, 146(4), 147-152.

Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004. / Márk, László; Zámolyi, Károly; Pados, Gyula; Paragh, G.; Ofner, Péter.

In: Orvosi Hetilap, Vol. 146, No. 4, 2005, p. 147-152.

Research output: Contribution to journalArticle

Márk, L, Zámolyi, K, Pados, G, Paragh, G & Ofner, P 2005, 'Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004', Orvosi Hetilap, vol. 146, no. 4, pp. 147-152.
Márk, László ; Zámolyi, Károly ; Pados, Gyula ; Paragh, G. ; Ofner, Péter. / Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004. In: Orvosi Hetilap. 2005 ; Vol. 146, No. 4. pp. 147-152.
@article{e75721f39fd646f1875fdbcccc7a3b3f,
title = "C{\'e}l{\'e}rt{\'e}kek el{\'e}r{\'e}se lipidcs{\"o}kkento kezel{\'e}s sor{\'a}n - Magyarorsz{\'a}g 2004",
abstract = "Introduction: Recent European and Hungarian guidelines of cardiovascular prevention have clearly defined the target levels in lipid lowering therapy. Objective: To analyze the risk status of patients receiving long term lipid lowering therapy and the rate of achievement of target level in a Hungarian multicenter trial. Method: The investigation was performed in January and February of 2004 involving general practitioners and specialists (cardiologists, lipidologists). Applying a questionnaire the authors asked for risk factors and the further implementations in the knowledge of results of each doctors' 10 consecutive patients receiving lipid lowering therapy for at least one year. Results: LDL target levels accepted by the Hungarian Therapic Consensus Conference was achieved in 22{\%} of GP's patients and 27{\%} of specialists' ones, averagely in 24{\%} of patients. According to risk stratification, the 83{\%} of patients receiving lipid lowering therapy were at high risk, and 79{\%} of these did not reach the suggested target level of serum total cholesterol. In 54{\%} of patients not achieving target level the doctors continue the therapy without any modification. Considering therapy modification in the rest of patients, a dose increase was intended in 61{\%}, change of drug in 31{\%} of cases, and rarely the combination therapy. Conclusion: While only a quarter of patients receiving lipid lowering treatment achieved the target levels, along with wide spreading of this kind of therapy further efforts should be made in order to achieve the levels defined in guidelines with dose increase or combination of appropriate drugs.",
keywords = "Cholesterol target levels, Lipid lowering therapy, Prevention",
author = "L{\'a}szl{\'o} M{\'a}rk and K{\'a}roly Z{\'a}molyi and Gyula Pados and G. Paragh and P{\'e}ter Ofner",
year = "2005",
language = "Hungarian",
volume = "146",
pages = "147--152",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "4",

}

TY - JOUR

T1 - Célértékek elérése lipidcsökkento kezelés során - Magyarország 2004

AU - Márk, László

AU - Zámolyi, Károly

AU - Pados, Gyula

AU - Paragh, G.

AU - Ofner, Péter

PY - 2005

Y1 - 2005

N2 - Introduction: Recent European and Hungarian guidelines of cardiovascular prevention have clearly defined the target levels in lipid lowering therapy. Objective: To analyze the risk status of patients receiving long term lipid lowering therapy and the rate of achievement of target level in a Hungarian multicenter trial. Method: The investigation was performed in January and February of 2004 involving general practitioners and specialists (cardiologists, lipidologists). Applying a questionnaire the authors asked for risk factors and the further implementations in the knowledge of results of each doctors' 10 consecutive patients receiving lipid lowering therapy for at least one year. Results: LDL target levels accepted by the Hungarian Therapic Consensus Conference was achieved in 22% of GP's patients and 27% of specialists' ones, averagely in 24% of patients. According to risk stratification, the 83% of patients receiving lipid lowering therapy were at high risk, and 79% of these did not reach the suggested target level of serum total cholesterol. In 54% of patients not achieving target level the doctors continue the therapy without any modification. Considering therapy modification in the rest of patients, a dose increase was intended in 61%, change of drug in 31% of cases, and rarely the combination therapy. Conclusion: While only a quarter of patients receiving lipid lowering treatment achieved the target levels, along with wide spreading of this kind of therapy further efforts should be made in order to achieve the levels defined in guidelines with dose increase or combination of appropriate drugs.

AB - Introduction: Recent European and Hungarian guidelines of cardiovascular prevention have clearly defined the target levels in lipid lowering therapy. Objective: To analyze the risk status of patients receiving long term lipid lowering therapy and the rate of achievement of target level in a Hungarian multicenter trial. Method: The investigation was performed in January and February of 2004 involving general practitioners and specialists (cardiologists, lipidologists). Applying a questionnaire the authors asked for risk factors and the further implementations in the knowledge of results of each doctors' 10 consecutive patients receiving lipid lowering therapy for at least one year. Results: LDL target levels accepted by the Hungarian Therapic Consensus Conference was achieved in 22% of GP's patients and 27% of specialists' ones, averagely in 24% of patients. According to risk stratification, the 83% of patients receiving lipid lowering therapy were at high risk, and 79% of these did not reach the suggested target level of serum total cholesterol. In 54% of patients not achieving target level the doctors continue the therapy without any modification. Considering therapy modification in the rest of patients, a dose increase was intended in 61%, change of drug in 31% of cases, and rarely the combination therapy. Conclusion: While only a quarter of patients receiving lipid lowering treatment achieved the target levels, along with wide spreading of this kind of therapy further efforts should be made in order to achieve the levels defined in guidelines with dose increase or combination of appropriate drugs.

KW - Cholesterol target levels

KW - Lipid lowering therapy

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=15744403166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15744403166&partnerID=8YFLogxK

M3 - Article

C2 - 15751508

AN - SCOPUS:15744403166

VL - 146

SP - 147

EP - 152

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 4

ER -